Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Veterinary Pathology
|
January 22, 2000
Feline papillomas and papillomaviruses
J P Sundberg, M Van Ranst, R Montali, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 6, 2001
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J
E Fontaine, C Riva, M Peeters, et al.
Clinical and Diagnostic Laboratory Immunology
|
January 4, 2001
Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay
T Lazzarotto, C Galli, R Pulvirenti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 8, 2000
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations
K Van Laethem, K Van Vaerenbergh, J C Schmit, et al.
AIDS Research and Human Retroviruses
|
April 18, 2002
Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients
K Van Vaerenbergh, T Harrer, J-C Schmit, et al.
Antiviral Therapy
|
June 22, 2001
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium
K Van Vaerenbergh, L Debaisieux, N De Cabooter, et al.
HIV Medicine
|
July 30, 2015
Late presentation to HIV testing is overestimated when based on the consensus definition
A Sasse, E Florence, A Pharris, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 4, 2014
Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses
J Matthijnssens, M Zeller, E Heylen, et al.
AIDS Research and Human Retroviruses
|
June 30, 2000
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients
K Van Laethem, J C Schmit, H Pelemans, et al.
The Journal of Infectious Diseases
|
October 14, 2009
Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data
M Iturriza-Gómara, T Dallman, K Bányai, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Veterinary Pathology
|
January 22, 2000
Feline papillomas and papillomaviruses
J P Sundberg, M Van Ranst, R Montali, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 6, 2001
Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J
E Fontaine, C Riva, M Peeters, et al.
Clinical and Diagnostic Laboratory Immunology
|
January 4, 2001
Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay
T Lazzarotto, C Galli, R Pulvirenti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 8, 2000
Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations
K Van Laethem, K Van Vaerenbergh, J C Schmit, et al.
AIDS Research and Human Retroviruses
|
April 18, 2002
Initiation of HAART in drug-naive HIV type 1 patients prevents viral breakthrough for a median period of 35.5 months in 60% of the patients
K Van Vaerenbergh, T Harrer, J-C Schmit, et al.
Antiviral Therapy
|
June 22, 2001
Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium
K Van Vaerenbergh, L Debaisieux, N De Cabooter, et al.
HIV Medicine
|
July 30, 2015
Late presentation to HIV testing is overestimated when based on the consensus definition
A Sasse, E Florence, A Pharris, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
March 4, 2014
Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses
J Matthijnssens, M Zeller, E Heylen, et al.
AIDS Research and Human Retroviruses
|
June 30, 2000
Presence of 2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5"-(4"-amino-1",2"-oxath iole-2",2"-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients
K Van Laethem, J C Schmit, H Pelemans, et al.
The Journal of Infectious Diseases
|
October 14, 2009
Rotavirus surveillance in europe, 2005-2008: web-enabled reporting and real-time analysis of genotyping and epidemiological data
M Iturriza-Gómara, T Dallman, K Bányai, et al.
Page
of 9